Get the Stockscreener App
0.3918
1.98%
0.0076
Osr Health Inc stock is traded at $0.3918, with a volume of 782.87K.
It is up +1.98% in the last 24 hours and down -25.04% over the past month.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.
See More
Previous Close:
$0.3842
Open:
$0.3788
24h Volume:
782.87K
Relative Volume:
0.13
Market Cap:
$13.75M
Revenue:
$2.63M
Net Income/Loss:
$-19.13M
P/E Ratio:
-1.0929
EPS:
-0.3585
Net Cash Flow:
$-5.27M
1W Performance:
-6.54%
1M Performance:
-25.04%
6M Performance:
-31.60%
1Y Performance:
-75.81%
1-Day Range:
$0.371
$0.3918
1-Week Range:
$0.367
$0.4178
52-Week Range:
$0.367
$1.79
Osr Health Inc Stock (OSRH) Company Profile
Name
Osr Health Inc
Sector
Industry
Phone
425-635-7700
Address
10900 NE 4TH STREET, SUITE 2300, BELLEVUE
Compare OSRH vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OSRH
Osr Health Inc
|
0.3918 | 13.75M | 2.63M | -19.13M | -5.27M | -0.3585 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Osr Health Inc Stock (OSRH) Latest News
OSR Holdings Inc (OSRH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OSR Holdings Inc (OSRH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OSR Holdings Inc (OSRH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OSR Health changes corporate name, maintains Nasdaq trading symbols - Investing.com UK
OSR Holdings Changes Corporate Name To OSR Health, Effective June 11, 2026 - TradingView
OSR Holdings Rebrands as OSR Health in Name Change - TipRanks
OSR Holdings Inc (OSRH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OSR Holdings Inc (OSRH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OSR Holdings Inc (OSRH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OSR HOLDINGS INC (OSRH) Stock Chart - ChartMill
OSR Holdings stock surges over 41% after hours: Why is it moving? - MSN
OSR Holdings Postpones 2026 Annual Stockholders Meeting - TipRanks
OSR Holdings postpones 2026 annual meeting; new date to be announced - TradingView
OSR Holdings (OSRH) delays 2026 annual stockholder meeting, new date pending - Stock Titan
OSR Holdings (OSRH) Inches Higher as It Tests Key Resistance LevelBear Flag - newsline.com
OSR Holdings Inc. (OSRH) Slips 6.73% as Stock Tests Key Support Near $0.37Hedge Fund Exposure - newsline.com
Why Did OSRH Stock Jump 20% Today? - Stocktwits
OSRH Q4 2025 Earnings: Significant EPS Miss Amid Operational HeadwindsShare Repurchase Impact - newsline.com
OSR Holdings CEO Shareholder Update June 2026 - ACCESS Newswire
CEO Statement to Shareholders - guardonline.com
OSR Holdings Secures VXM01 Rights in Asset Deal - TipRanks
OSR Holdings to Acquire VXM01 IP From Vaximm for $30 Million, Payment Linked to Phase 2 Milestone - TradingView
OSR Holdings (NASDAQ: OSRH) secures direct ownership of VXM01 IP - Stock Titan
OSR Holdings Warrant (OSRHW) Holds at $0.06 After Marginal GainsMotive Wave - The Legal Advocate
OSR Holdings (OSRH) Slips 2.15%, Tests Critical Support at $0.43Cash Flow Strong Stocks - newsline.com
OSRH Q4 2025 Earnings: EPS Misses Estimates by 56.86% as Stock Declines 5.17%Basic EPS Analysis - The Legal Advocate
OSR Holdings Inc. (OSRH) Faces Selling Pressure Near Support – Key Levels to WatchMoney Flow - newsline.com
OSR Holdings Acquires VXM01 Intellectual Property Portfolio in $30 Million Deal Completed May 27, 2026 - geneonline.com
OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction - PharmiWeb.com
OSR Holdings to acquire VXM01 IP portfolio for $30 million By Investing.com - Investing.com Australia
OSR Holdings Company Profile & Introduction - Moomoo
OSR Holdings to acquire VXM01 IP portfolio for $30 million - Investing.com
OSR Holdings Acquires VXM01 IP Portfolio for $30M - ACCESS Newswire
OSRH Q4 2025 Earnings: EPS Miss of 56.9% Triggers Stock DeclineEarnings Per Share - The Legal Advocate
OSR Holdings, Inc. agreed to acquire Full VXM01 Intellectual Property Portfolio of VAXIMM AG from Vaximm AG for $30 million. - marketscreener.com
OSRH - Finviz
OSR Holdings (NASDAQ: OSRH) seeks votes on name change and equity plan - Stock Titan
OSRH Q4 2025 Earnings: EPS Misses Estimates as Company Navigates Operational ChallengesEarnings Surprise Stocks - The Legal Advocate
OSR Holdings Inc. (OSRH) Edges Lower as Stock Tests Key Support at $0.47Dividend Growth Stocks - Newser
OSR Holdings Warrant (OSRHW) Sees Modest Uptick, Trading Near Support at $0.06Statistical Arbitrage - newsline.com
OSR appoints Andreas Niethammer as Chief Medical Officer of Vaximm AG - MSN
OSR Holdings Q4 2025 Earnings: EPS Misses Estimates Amidst Weak Market SentimentEBITDA Margin Trends - Newser
OSRH Q4 2025 Earnings: EPS Misses Estimates by 56.86%, Shares DeclineEarnings Beat Streak - thelegaladvocate.com
OSRH News | OSR HOLDINGS INC (NASDAQ:OSRH) - ChartMill
OSR Holdings (OSRH) Q4 2025 Earnings: Miss Sparks ConcernDownward Estimate Revision - Newser
OSR Holdings (OSRH) Falls -1.94% — Watching $0.47 Support 2026-05-20Straddle Setup - Newser
Should You Sell OSR Holdings (OSRH) After -8.25% Drop? 2026-05-18High Interest Stocks - Newser
Number of shareholders of OSR Holdings, Inc. – NASDAQ:OSRH - TradingView
TradingKey - TradingKey
OSR Holdings, Inc. Q1 2026 Financial Report: Business Combination, Subsidiary Overview, and Key Financial Results - Minichart
OSR Holdings, Inc. 1Q 2026: Revenue $484.1K, EPS $(0.08) — 10-Q Summary - TradingView
Osr Health Inc Stock (OSRH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):